Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 12, 2018

DrugPatentWatch Database Preview

United Therap Company Profile

« Back to Dashboard

What is the competitive landscape for UNITED THERAP, and what generic alternatives to UNITED THERAP drugs are available?

UNITED THERAP has four approved drugs.

There are twenty-three US patents protecting UNITED THERAP drugs.

Summary for United Therap

US Patents:	23
Tradenames:	3
Ingredients:	2
NDAs:	4
Patent Litigation for United Therap:	See patent lawsuits for United Therap
PTAB Cases with United Therap as patent owner:	See PTAB cases with United Therap as patent owner

Drugs and US Patents for United Therap

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-002	May 21, 2002	AP	RX	Yes	Yes	8,653,137	➤ Sign Up				➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-001	Dec 20, 2013		RX	Yes	No	7,544,713	➤ Sign Up				➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-003	Dec 20, 2013		RX	Yes	No	9,593,066	➤ Sign Up		Y		➤ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-002	May 21, 2002	AP	RX	Yes	Yes	7,999,007	➤ Sign Up	Y			➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-003	Dec 20, 2013		RX	Yes	No	8,747,897	➤ Sign Up	Y			➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-001	Dec 20, 2013		RX	Yes	No	9,278,901	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for United Therap

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-004	Dec 20, 2013	5,153,222	➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-002	Dec 20, 2013	5,153,222	➤ Sign Up
United Therap	ORENITRAM	treprostinil diolamine	TABLET, EXTENDED RELEASE;ORAL	203496-003	Dec 20, 2013	6,765,117	➤ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-004	May 21, 2002	5,153,222	➤ Sign Up
United Therap	TYVASO	treprostinil	SOLUTION;INHALATION	022387-001	Jul 30, 2009	5,153,222	➤ Sign Up
United Therap	REMODULIN	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	021272-001	May 21, 2002	5,153,222	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for UNITED THERAP drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	10 mg/mL, 20 mL vial	➤ Subscribe	2011-12-02
➤ Subscribe	Inhalation Solution	0.6 mg/mL, 2.9 mL ampules	➤ Subscribe	2015-04-13
➤ Subscribe	Extended-release Tablets	0.25 mg and 1 mg	➤ Subscribe	2016-05-19
➤ Subscribe	Injection	1 mg/mL, 2.5 mg/mL, and 5 mg/mL, 20 mL vial	➤ Subscribe	2012-12-07
➤ Subscribe	Extended-release Tablets	2.5 mg	➤ Subscribe	2015-12-24

International Patents for United Therap Drugs

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
European Patent Office	1696900	➤ Sign Up
Japan	2016026155	➤ Sign Up
Spain	2347254	➤ Sign Up
China	102421288	➤ Sign Up
Japan	5649645	➤ Sign Up
South Korea	101693049	➤ Sign Up
Country	Document Number	Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission

Teva

Merck

Cantor Fitzgerald

Express Scripts

Argus Health

Deloitte

Mallinckrodt

Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.